Advertisement
Loading...

Invivyd, Inc.

IVVDNASDAQ
Healthcare
Biotechnology
$1.15
$-0.32(-21.78%)
U.S. Market is Open • 09:51

Invivyd, Inc. Fundamental Analysis

Invivyd, Inc. (IVVD) shows weak financial fundamentals with a PE ratio of -4.69, profit margin of -1.39%, and ROE of -53.48%. The company generates $0.0B in annual revenue with weak year-over-year growth of 1.10%.

Key Strengths

Cash Position51.27%
PEG Ratio-0.04
Current Ratio6.47

Areas of Concern

ROE-53.48%
Operating Margin-1.46%
We analyze IVVD's fundamental strength across five key dimensions.

The stock receives a Fundamental Health Score of -108.5/100 based on profitability, valuation, growth, and balance sheet metrics. The F grade reflects weak fundamentals and significant financial concerns.

Fundamental Health Score

F
-108.5/100

We analyze IVVD's fundamental strength across five key dimensions:

Efficiency Score

Weak

IVVD struggles to generate sufficient returns from assets.

ROA > 10%
-32.10%

Valuation Score

Excellent

IVVD trades at attractive valuation levels.

PE < 25
-4.69
PEG Ratio < 2
-0.04

Growth Score

Moderate

IVVD shows steady but slowing expansion.

Revenue Growth > 5%
1.10%
EPS Growth > 10%
79.02%

Financial Health Score

Excellent

IVVD maintains a strong and stable balance sheet.

Debt/Equity < 1
0.04
Current Ratio > 1
6.47

Profitability Score

Weak

IVVD struggles to sustain strong margins.

ROE > 15%
-5347.60%
Net Margin ≥ 15%
-1.39%
Positive Free Cash Flow
No

Key Financial Metrics

Is IVVD Expensive or Cheap?

P/E Ratio

IVVD trades at -4.69 times earnings. This suggests potential undervaluation.

-4.69

PEG Ratio

When adjusting for growth, IVVD's PEG of -0.04 indicates potential undervaluation.

-0.04

Price to Book

The market values Invivyd, Inc. at 1.79 times its book value. This may indicate undervaluation.

1.79

EV/EBITDA

Enterprise value stands at -4.15 times EBITDA. This is generally considered low.

-4.15

How Well Does IVVD Make Money?

Net Profit Margin

For every $100 in sales, Invivyd, Inc. keeps $-1.39 as profit after all expenses.

-1.39%

Operating Margin

Core operations generate -1.46 in profit for every $100 in revenue, before interest and taxes.

-1.46%

ROE

Management delivers $-53.48 in profit for every $100 of shareholder equity.

-53.48%

ROA

Invivyd, Inc. generates $-32.10 in profit for every $100 in assets, demonstrating efficient asset deployment.

-32.10%

Following the Money - Real Cash Generation

Operating Cash Flow

Invivyd, Inc. generates limited operating cash flow of $-33.74M, signaling weaker underlying cash strength.

$-33.74M

Free Cash Flow

Invivyd, Inc. generates weak or negative free cash flow of $-34.06M, restricting financial flexibility.

$-34.06M

FCF Per Share

Each share generates $-0.26 in free cash annually.

$-0.26

FCF Yield

IVVD converts -51.37% of its market value into free cash.

-51.37%

Financial Ratios Analysis

Valuation Ratios

P/E Ratio

Price to earnings ratio

-4.69

vs 25 benchmark

PEG Ratio

Price/earnings to growth ratio

-0.04

vs 25 benchmark

P/B Ratio

Price to book value ratio

1.79

vs 25 benchmark

P/S Ratio

Price to sales ratio

2.79

vs 25 benchmark

Financial Health

Debt/Equity

Total debt to shareholders' equity

0.04

vs 25 benchmark

Current Ratio

Current assets to current liabilities

6.47

vs 25 benchmark

Efficiency Ratios

ROE

Return on equity percentage

-0.53

vs 25 benchmark

ROA

Return on assets percentage

-0.32

vs 25 benchmark

ROCE

Return on capital employed

-0.39

vs 25 benchmark

How IVVD Stacks Against Its Sector Peers

MetricIVVD ValueSector AveragePerformance
P/E Ratio-4.6929.36 Better (Cheaper)
ROE-53.48%733.00% Weak
Net Margin-138.90%-46094.00% (disorted) Weak
Debt/Equity0.040.46 Strong (Low Leverage)
Current Ratio6.474.35 Strong Liquidity
ROA-32.10%-21034.00% (disorted) Weak

IVVD outperforms its industry in 3 out of 6 key metrics, but lagging in ROE.

Historical Growth Performance

5-Year Growth Trajectory

This section reviews Invivyd, Inc.'s 5-year compound annual growth rate (CAGR) and compares its performance against the typical investment style of its industry.

Revenue CAGR

0.00%

Industry Style: Defensive, Growth, Innovation

Declining

EPS CAGR

69.72%

Industry Style: Defensive, Growth, Innovation

High Growth

FCF CAGR

-157.73%

Industry Style: Defensive, Growth, Innovation

Declining

Fundamental Analysis FAQ